Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosis

Project description

Innovative coating for intravenous catheters and implantable devices

Catheters and implantable devices that come into contact with the bloodstream can lead to blood infections and thrombosis, which are significant causes of morbidity and mortality in intensive care units and contribute to increased healthcare costs. Currently, there is no available coating technology to simultaneously prevent these complications. The EIC-funded Coati-X project proposes a coating technology aimed at preventing thrombosis and internal bloodstream infections. The cross-linked nanogel coating is capable of containing antithrombotic and antibiotic drugs. This technology utilises nanoreservoirs to capture various bioactive molecules, thus combining multiple biological activities in a single layer. It is adaptable to any biomaterial or medical device. The project’ goal is to expedite the development of Coati-X and introduce it to the market.

Objective

Catheters and implantable medical devices contacting with the bloodstream are sources of internal blood infections and thrombosis. Catheter-related bloodstream infections are one of the major causes of patient morbidity and mortality in intensive care units. Both thrombosis and catheter-related infections are leading to prolonged hospital stay, increased risks of mortality and high costs for healthcare system. Currently there is no coating technology on the market that allows preventing these two complications at once. We developed a new innovative coating technology that enables simultaneous prevention of thrombosis and internal bloodstream infections. This coating is made of layer-by-layer cross-linked nanogels that can be loaded with an antithrombotic and/or antibiotic drug. We found that layer-by-layer assembly of these nanogels controls the amount of releasable bioactive agents from coated-surfaces. Innovation of our technology is linked to the wider space of used nanoreservoirs that can entrap several bioactive molecules thus combining several biological activities in a single coating. In addition, these nanoreservoirs can be deposited as a coating on the surface of any biomaterial or medical device, whether metallic, biological, or polymeric.
We have built a consortium that combines the key technical and business experience to bring our innovative coating product to market readiness. CMD-Coat, a young SME, counts with top researchers and specialists in the field of cardiovascular diseases, biologists, chemists and pharmacist. Fresci is a company specializing on the business strategy and innovation management. Together we aim to accelerate the technological development and validation of our Coati-X technology and bring to the market a new bioactive coating solution for implantable medical devices.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIC-2023-TRANSITION-01

See all projects funded under this call

Coordinator

CM4CURE SA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 2 074 350,00
Address
AVENUE DE L'HOPITAL 1
4000 Liege
Belgium

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Région wallonne Prov. Liège Arr. Liège
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 074 350,00

Participants (1)

My booklet 0 0